Partnership
Committed to Building Synergies with Our Partners to Bring Innovative Solutions for Patients.
Why Partner with Us
Partnerships are integral to Harbour BioMed's strategic vision of building a fully integrated biopharmaceutical company. We operate global R&D centers in the USA, Europe, and China to identify and leverage local innovation for global development.
Our growing innovative portfolio reflects successful collaborations with industry and academic institutions worldwide, concentrated in the fields of immunology, immuno-oncology and more.
-
Innovative Platforms
-
End-to-End Capabilities
Technology Service
High quality technology support through fee for service and FTE
Technology License
Access to world's leading fully human Harbour Mice® platform
Asset License
Novel pipelines with best-in class potential for global innovation
Co-development
Leverage synergistic advantages to collaboratively develop breakthrough therapies
Strategic Collaboration
Comprehensive long-term collaboration utilizing Harbour's proprietary platform to develop next-gen therapeutics
-
01
Technology Service
>100 Partners
-
02
Technology License
-
03
Asset License
-
04
Co-development
-
05
Strategic Collaboration
Email Us at:
For Partnership Enquires: BD@harbourbiomed.com
Copyright © 2025 Harbour BioMed. All Rights Reserved
沪公网安备31011502401396号
沪ICP备19015946号-1